<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-SLE03SBJJH"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-SLE03SBJJH');
</script>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Rheumatic Heart Disease (RHD)</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->


      <h1>Rheumatic Heart Disease (RHD)</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
        <!-- READ SUMMARY CONTAINER -->
        
              <!-- Summary Overlay -->
              <div class="summary-overlay" id="summaryOverlay"></div>
        
        
              <div class="summary-card" id="summaryCard">
                
                <div class="summary-header">
                  <h3>Note Summary</h3>
                  <div class="icon-box">
                    <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                    <img src="../images/icons/summary.png" alt="Icon" class="icon">
                  </div>
                </div>
                <div class="summary-content">
                  <!-- Summary content goes here -->
                  <p><i>This content is not available yet.</i></p>
        
                  <span class="close-btn" id="closeBtn">close</span>
                </div>
              </div>
        
              <div class="summary-trigger" id="summaryTrigger">
                <p>Click here to read a summary</p>
            </div>
        <!-- END OF READ SUMMARY CONTAINER -->
        
            <!-- BEGINNING OF NOTE -->
        
            <section id='header-1'>
                <header>
                  <h2>
                    <a aria-hidden='true' href='#header-1'>Introduction</a>
                  </h2>
                </header>
                <div class='body'>
                  <p>
                    Rheumatic Heart Disease (RHD) is a chronic and progressive condition resulting from damage to the heart following one or more episodes of Acute Rheumatic Fever (ARF). It is characterized by permanent structural damage to cardiac valves, chordae tendineae, and papillary muscles. ARF primarily arises as a non-suppurative sequela of infection with group A Œ≤-hemolytic streptococci (GABHS).
                  </p>
                </div>
              </section>

              <section id='header-2'>
                <header>
                  <h2>
                    <a aria-hidden='true' href='#header-2'>Etiology and Pathophysiology</a>
                  </h2>
                </header>
                <div class='body'>
                  <p><strong>Etiology:</strong> RHD develops due to a delayed autoimmune response triggered by <strong>GABHS infection</strong>.</p>
                  <p><strong>Pathophysiology:</strong></p>
                  <ul>
                    <li>The immune system cross-reacts with host tissues due to molecular mimicry between <strong>streptococcal M proteins</strong> and human proteins.</li>
                    <li>Affects multiple systems including:
                      <ul>
                        <li><strong>Heart:</strong> Pancarditis during ARF</li>
                        <li><strong>Joints:</strong> Migratory arthritis</li>
                        <li><strong>Central Nervous System (CNS):</strong> Sydenham chorea</li>
                        <li><strong>Skin:</strong> Erythema marginatum and subcutaneous nodules</li>
                      </ul>
                    </li>
                  </ul>
                </div>
              </section>
              

              <section id='header-3'>
                <header>
                  <h2>
                    <a aria-hidden='true' href='#header-3'>Clinical Features of Acute Rheumatic Fever (ARF)</a>
                  </h2>
                </header>
                <div class='body'>
                  <p><strong>Non-Specific Features</strong></p>
                  <ul>
                    <li><strong>Peak age:</strong> 6‚Äì15 years.</li>
                    <li><strong>History of sore throat:</strong> 2‚Äì4 weeks before presentation.</li>
                    <li><strong>Symptoms:</strong> Fever, myalgia, abdominal pain, epistaxis, and cough.</li>
                    <li><strong>Duration:</strong> Typically resolves in 5‚Äì7 days.</li>
                  </ul>
                  <p><strong>Syndromic Features (Major Criteria)</strong></p>
                  <ol>
                    <li><strong>Arthritis:</strong>
                      <ul>
                        <li>Migratory polyarthritis affecting large joints.</li>
                        <li>Pain, swelling, and warmth.</li>
                        <li>Seen in ~75% of cases.</li>
                      </ul>
                    </li>
                    <li><strong>Pancarditis:</strong>
                      <ul>
                        <li>Inflammation of the entire heart, present in 50% of ARF cases.</li>
                        <li><strong>Clinical signs:</strong>
                          <ul>
                            <li>Mitral regurgitation.</li>
                            <li>Heart failure symptoms: Cough, dyspnea, leg swelling.</li>
                            <li><strong>Murmur:</strong> Grade III-IV holosystolic murmur heard best at the apex, radiating to the axilla.</li>
                          </ul>
                        </li>
                      </ul>
                    </li>
                    <li><strong>Sydenham Chorea:</strong>
                      <ul>
                        <li>Neurological and psychological manifestations in 15% of cases.</li>
                        <li><strong>Features:</strong> Tremors, altered handwriting, milkmaid grip, and psychological symptoms like insomnia, hallucinations, mania, or depression.</li>
                        <li>Common in prepubertal females; manifests 2‚Äì6 months post-infection.</li>
                      </ul>
                    </li>
                    <li><strong>Erythema Marginatum:</strong>
                      <ul>
                        <li>Circular rash with a pale center and red margins, affecting the trunk and limbs (5‚Äì10% of cases).</li>
                      </ul>
                    </li>
                    <li><strong>Subcutaneous Nodules:</strong>
                      <ul>
                        <li>Painless, firm nodules under the skin, rare (&lt;5% of cases).</li>
                      </ul>
                    </li>
                  </ol>
                </div>
              </section>

              <section id='header-4'>
                <header>
                  <h2>
                    <a aria-hidden='true' href='#header-4'>Diagnosis</a>
                  </h2>
                </header>
                <div class='body'>
                  <p>The <strong>Modified Duckett Jones Criteria</strong> is used for diagnosing ARF.</p>
                  <ul>
                    <li><strong>Major Criteria:</strong> Syndromic features (arthritis, pancarditis, Sydenham chorea, erythema marginatum, subcutaneous nodules).</li>
                    <li><strong>Minor Criteria:</strong>
                      <ul>
                        <li><strong>Clinical:</strong> Fever, arthralgia.</li>
                        <li><strong>Laboratory:</strong> Elevated ESR, prolonged PR interval (first-degree heart block), and evidence of recent GABHS infection (e.g., throat swab culture or rising antibody titer).</li>
                      </ul>
                    </li>
                  </ul>
                  <p>Effective diagnosis of ARF and RHD relies on clinical assessment, laboratory investigations, and imaging techniques to evaluate systemic involvement, confirm underlying infections, and identify cardiac damage.</p>
              
                  <h4>1. Clinical Assessment</h4>
                  <ul>
                    <li><strong>Thorough Evaluation:</strong>
                      <ul>
                        <li>Symptoms of ARF include fever, arthralgia, and syndromic features such as arthritis, pancarditis, Sydenham chorea, erythema marginatum, and subcutaneous nodules.</li>
                        <li><strong>Diagnostic Criteria:</strong>
                          <ul>
                            <li><strong>Major Criteria:</strong> Arthritis, pancarditis, Sydenham chorea, erythema marginatum, subcutaneous nodules.</li>
                            <li><strong>Minor Criteria:</strong> Fever, arthralgia.</li>
                          </ul>
                        </li>
                      </ul>
                    </li>
                    <li><strong>Diagnostic Approach:</strong>
                      Diagnosis follows the Modified Duckett Jones Criteria:
                      <ul>
                        <li>2 Major Criteria, or 1 Major + 2 Minor Criteria, along with evidence of preceding GABHS infection.</li>
                      </ul>
                    </li>
                  </ul>
              
                  <h4>2. Laboratory Investigations</h4>
                  <ol>
                    <li><strong>Markers of Cardiac and Systemic Inflammation:</strong>
                      <ul>
                        <li><strong>Prolonged PR Interval:</strong> Identified via <strong>Electrocardiogram (ECG)</strong>, prolonged PR interval is a sign of first-degree heart block (minor criterion).</li>
                        <li><strong>Elevated ESR:</strong> Non-specific inflammation marker; part of the minor criteria.</li>
                      </ul>
                    </li>
                    <li><strong>Evidence of Recent GABHS Infection:</strong>
                      <ul>
                        <li><strong>Throat Swab Culture:</strong> A positive culture for GABHS strongly supports the diagnosis.</li>
                        <li><strong>Rapid Antigen Test:</strong> Confirms Group A Streptococcal presence quickly.</li>
                        <li><strong>Streptococcal Antibody Titers:</strong>
                          <ul>
                            <li><strong>Antistreptolysin O (ASO) Titer:</strong> >333 Todd units in children, >250 Todd units in adults.</li>
                            <li><strong>Antihyaluronidase and Antideoxyribonuclease B Titers:</strong> >240 Todd units in children, >120 Todd units in adults.</li>
                          </ul>
                        </li>
                      </ul>
                    </li>
                  </ol>
              
                  <h4>3. Imaging and Other Diagnostic Modalities</h4>
                  <ol>
                    <li><strong>Echocardiography (ECHO):</strong>
                      <ul>
                        <li>Crucial for assessing valvular defects, abnormal blood flow, and structural damage in RHD.</li>
                        <li>In cases of <strong>Infective Endocarditis</strong>, ECHO can identify vegetations and confirm underlying heart disease.</li>
                      </ul>
                    </li>
                    <li><strong>Chest X-Ray (CXR):</strong>
                      <ul>
                        <li>May show straightening of the left heart border due to left atrial enlargement in advanced RHD.</li>
                      </ul>
                    </li>
                    <li><strong>Electrocardiogram (ECG):</strong>
                      <ul>
                        <li>Identifies prolonged PR interval, arrhythmias, left atrial enlargement, and left ventricular hypertrophy.</li>
                      </ul>
                    </li>
                    <li><strong>Cardiac Catheterization:</strong>
                      <ul>
                        <li>Reserved for detailed structural and functional cardiac assessment in complex cases.</li>
                      </ul>
                    </li>
                  </ol>
              
                  <h4>4. Investigations for Infective Endocarditis</h4>
                  <ol>
                    <li><strong>Serial Blood Cultures:</strong>
                      <ul>
                        <li>At least 3 blood samples taken to detect causative microorganisms.</li>
                        <li>If cultures remain negative after 48 hours, additional samples are required.</li>
                      </ul>
                    </li>
                    <li><strong>ECHO:</strong>
                      <ul>
                        <li>Identifies vegetations, valve destruction, and regurgitation.</li>
                      </ul>
                    </li>
                    <li><strong>Full Blood Count (FBC):</strong>
                      <ul>
                        <li>May show anemia and left shift leukocytosis, indicating infection or inflammation.</li>
                      </ul>
                    </li>
                    <li><strong>Urinalysis:</strong>
                      <ul>
                        <li>Microscopic hematuria, if present, can be associated with embolic phenomena.</li>
                      </ul>
                    </li>
                  </ol>
              
                  <h4>Key Diagnostic Notes</h4>
                  <ul>
                    <li><strong>Jones Criteria:</strong>
                      <ul>
                        <li>A single major criterion can diagnose ARF in cases of:</li>
                        <ul>
                          <li>Isolated chorea.</li>
                          <li>Indolent carditis.</li>
                          <li>Recurrence in a patient with previous ARF.</li>
                        </ul>
                      </ul>
                    </li>
                    <li><strong>Diagnostic Confirmation:</strong> Evidence of preceding GABHS infection is critical for diagnosis, emphasizing the importance of throat swabs, antigen tests, and antibody titers.</li>
                  </ul>
                </div>
              </section>

              

              <section id="header-5">
                <header>
                  <h2><a aria-hidden="true" href="#header-5"></a>Chronic Sequelae of RHD</h2>
                </header>
                <div class="body">
              
                  <h4>Mitral Valve Disease in RHD</h4>
                  <ul>
                    <li><strong>Prevalence:</strong> Affects 90% of RHD patients.</li>
                    <li><strong>Mitral Stenosis:</strong>
                      <ul>
                        <li>More common in women.</li>
                        <li><strong>Pathology:</strong> Valve thickening, chordae tendineae shortening, and cusp fusion.</li>
                        <li><strong>Clinical features:</strong>
                          <ul>
                            <li>Asymptomatic until valve orifice < 2 cm¬≤.</li>
                            <li><strong>Symptoms:</strong> Cough, hemoptysis, dysphagia, palpitations, and heart failure.</li>
                            <li><strong>Murmur:</strong> Mid-diastolic rumble with an opening snap.</li>
                          </ul>
                        </li>
                      </ul>
                    </li>
                    <li><strong>Mitral Regurgitation:</strong>
                      <ul>
                        <li><strong>Symptoms:</strong> Bounding pulse, heart failure.</li>
                        <li><strong>Murmur:</strong> Holosystolic murmur at the apex, radiating to the axilla.</li>
                      </ul>
                    </li>
                  </ul>
              
                  <h4>Aortic Valve Disease</h4>
                  <ul>
                    <li><strong>Regurgitation:</strong>
                      <ul>
                        <li><strong>Clinical features:</strong> Wide pulse pressure, Quincke‚Äôs sign, De Musset‚Äôs sign, and pistol-shot sounds over femoral arteries.</li>
                        <li><strong>Murmur:</strong> Diastolic murmur at the right sternal edge.</li>
                      </ul>
                    </li>
                    <li><strong>Aortic Stenosis:</strong>
                      <ul>
                        <li><strong>Clinical features:</strong> Dyspnea, fainting, small volume pulse, and ejection systolic murmur radiating to the carotids.</li>
                        <li><strong>Associated with:</strong> William‚Äôs Syndrome.</li>
                      </ul>
                    </li>
                  </ul>
              
                  <h4>Pulmonary and Tricuspid Valve Disease</h4>
                  <p>While less common, RHD can also affect the pulmonary and tricuspid valves. Specific features are not elaborated in the source.</p>
                </div>
              </section>
              

              <section id="header-6">
                <header>
                  <h2><a aria-hidden="true" href="#header-6">Treatment</a></h2>
                </header>
                <div class="body">
                  <h4>Management of Acute Rheumatic Fever (ARF)</h4>
                  <ul>
                    <li><strong>Bed Rest:</strong> Adequate rest is crucial during the acute phase of ARF to alleviate inflammation and reduce strain on the heart.</li>
                    <li><strong>Anti-inflammatory Therapy:</strong>
                      <ul>
                        <li>Aspirin is commonly used to reduce inflammation, fever, and pain. It is the first-line treatment for controlling symptoms in the acute phase.</li>
                        <li>Steroids may be required in severe cases or when aspirin fails to adequately control symptoms, especially in cases involving the heart.</li>
                      </ul>
                    </li>
                    <li><strong>Heart Failure Management:</strong> If heart failure develops as a result of pancarditis, it must be promptly addressed with appropriate pharmacological therapy and, if necessary, other interventions.</li>
                    <li><strong>Management of Chorea:</strong> Medications such as haloperidol or phenobarbital may be used to control the involuntary movements associated with chorea.</li>
                  </ul>
              
                  <h4>Management of Rheumatic Heart Disease (RHD)</h4>
                  <ul>
                    <li><strong>Valvular Repair:</strong> In cases of significant valve damage, the goal is to repair or replace the affected heart valves. This may require either surgical intervention or a less invasive percutaneous procedure, depending on the severity.</li>
                    <li><strong>Heart Failure Management:</strong> RHD often leads to chronic heart failure due to valvular dysfunction. The management of heart failure in these patients should focus on controlling symptoms with medications such as ACE inhibitors, diuretics, and beta-blockers, alongside regular monitoring to assess disease progression.</li>
                  </ul>
                </div>
              </section>
              

              <section id="header-7">
                <header>
                  <h2><a aria-hidden="true" href="#header-7">Prevention of ARF and RHD</a></h2>
                </header>
                <div class="body">
                  <h4>Prevention of Acute Rheumatic Fever (ARF) and Rheumatic Heart Disease (RHD)</h4>
              
                  <h4>Primary Prophylaxis</h4>
                  <p>This aims to prevent the initial development of ARF by treating Group A Beta-Hemolytic Streptococcal (GABHS) pharyngitis.</p>
                  <ul>
                    <li>Oral penicillin is given for 7-10 days to patients with suspected or confirmed GABHS pharyngitis, effectively eradicating the infection and preventing the onset of ARF.</li>
                  </ul>
              
                  <h4>Secondary Prophylaxis</h4>
                  <p>This is critical for individuals with a history of ARF to prevent recurrent episodes.</p>
                  <ul>
                    <li>Intramuscular (IM) benzathine penicillin is administered every 3-4 weeks to reduce the risk of recurrence.</li>
                    <li>The duration of secondary prophylaxis is determined by the severity of carditis:
                      <ul>
                        <li><strong>No carditis:</strong> 5 years after the initial ARF episode or until the patient reaches 18 years of age, whichever is longer.</li>
                        <li><strong>Mild or healed carditis:</strong> 10 years or until age 25, whichever is longer.</li>
                        <li><strong>Severe carditis or valvular surgery:</strong> Lifelong prophylaxis is required.</li>
                      </ul>
                    </li>
                  </ul>
              
                  <h4>Additional Considerations for Prophylaxis</h4>
                  <p>The duration of prophylaxis depends on several factors:</p>
                  <ul>
                    <li>Age of the patient.</li>
                    <li>Number of previous ARF attacks.</li>
                    <li>Severity of existing heart disease.</li>
                    <li>Risk of exposure to streptococcal infections.</li>
                  </ul>
              
                  <h4>Infective Endocarditis Risk</h4>
                  <p>Patients with RHD are at an increased risk for infective endocarditis, particularly during invasive procedures. Prophylactic antibiotics are often recommended before dental or surgical procedures to reduce this risk.</p>
              
                  <h4>Goal of Treatment and Prevention</h4>
                  <p>The main aim of treatment and prophylaxis is to manage symptoms, prevent disease progression, and improve the long-term prognosis for patients with ARF and RHD. By adhering to prophylactic guidelines, the incidence of recurrent infections and subsequent heart damage can be minimized.</p>
                </div>
              </section>
              

              <section id="header-8">
                <header>
                  <h2><a aria-hidden="true" href="#header-8">Infective Endocarditis (IE)</a></h2>
                </header>
                <div class="body">
              
                  <h4>Definition</h4>
                  <p>Infective endocarditis (IE) is a microbial infection affecting the endocardial surface of the heart, typically involving the heart valves.</p>
              
                  <h4>Etiology</h4>
                  <p>The most common causative organisms are Staphylococcus aureus and Streptococcus species, including Group D streptococcus, which are responsible for approximately 60% of cases.</p>
                  <p>Other less common organisms include:</p>
                  <ul>
                    <li>Staphylococcus epidermidis</li>
                    <li>Coxiella burnetii</li>
                    <li>The HACEK group (Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella)</li>
                  </ul>
              
                  <h4>Risk Factors</h4>
                  <p>Structural heart defects significantly increase the risk of developing IE, with risk stratification as follows:</p>
                  <ul>
                    <li><strong>Highest risk:</strong> Conditions like Cyanotic Congenital Heart Disease (CHD) (particularly Tetralogy of Fallot (TOF)), prosthetic heart valves, and a previous history of infective endocarditis.</li>
                    <li><strong>High risk:</strong> Conditions such as Patent Ductus Arteriosus (PDA), Aortic Regurgitation (AR), Ventricular Septal Defect (VSD), Mitral Valve Prolapse (MVP), coarctation of the aorta, and intermediate MVP or stenosis with murmur.</li>
                    <li><strong>Low/no risk:</strong> Conditions like Atrial Septal Defect (ASD), Mitral Stenosis (MS), MVP without murmur, coronary artery disease, or those with implantable defibrillators.</li>
                  </ul>
                  <p>Other risk factors:</p>
                  <ul>
                    <li>Intravenous drug use.</li>
                    <li>The presence of indwelling devices such as catheters.</li>
                    <li>Recent procedures, including dental extractions or surgical operations.</li>
                  </ul>
              
                  <h4>Clinical Features</h4>
                  <p>Constitutional symptoms may include:</p>
                  <ul>
                    <li>Fever</li>
                    <li>Myalgia</li>
                    <li>Joint pains</li>
                  </ul>
                  <p>Other symptoms associated with heart failure may occur.</p>
                  <p>Patients may have a history of complications such as:</p>
                  <ul>
                    <li>Bloody urine</li>
                    <li>Renal infarcts (due to embolism)</li>
                    <li>Hemiparesis (due to cerebrovascular accidents)</li>
                  </ul>
                  <p>On examination, signs such as the following can be observed:</p>
                  <ul>
                    <li>Osler nodes</li>
                    <li>Janeway lesions</li>
                    <li>Petechiae</li>
                    <li>Splinter hemorrhages</li>
                  </ul>
                  <p>A new murmur or a change in an existing murmur may be detected. Splenomegaly can also be present.</p>
              
                  <h4>Investigations</h4>
                  <ul>
                    <li><strong>Serial blood cultures:</strong> At least three samples should be collected. If cultures are negative after 48 hours, two additional samples should be obtained. If cultures remain negative, no microbial growth is assumed.</li>
                    <li><strong>Echocardiography (ECHO):</strong> Essential to identify underlying heart disease, valve vegetations, and other defects associated with infective endocarditis.</li>
                    <li><strong>Full Blood Count (FBC):</strong> Anemia and left-shift leukocytosis are common findings.</li>
                    <li><strong>Urinalysis:</strong> Microscopic hematuria may be detected.</li>
                  </ul>
              
                  <h4>Prophylaxis</h4>
                  <p>Patients with Rheumatic Heart Disease (RHD) are at an increased risk of developing infective endocarditis.</p>
                  <p>These individuals may require prophylactic antibiotics prior to certain dental or surgical procedures to prevent infection.</p>
                </div>
              </section>
              

              <section id="header-9">
                <header>
                  <h2><a aria-hidden="true" href="#header-9">Conclusion</a> </h2>
                </header>
                <div class="body">
                  <p>Rheumatic Heart Disease remains a significant health burden in low-resource settings. Early diagnosis, effective treatment of ARF, and robust prophylaxis programs are critical to preventing RHD and its complications.</p>
                </div>
              </section>
              


      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://docs.google.com/forms/d/e/1FAIpQLSdx2teDCmW6ivSeKLQg7zF_jy7Yfg_1Gqm84_UT0PQPATsNug/viewform?usp=sf_link" class="comment-button">
            here
            <!-- <img src="../images/icons/whatsapp.png" alt="Image Icon"> -->
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>

<!-- Floating TOC Button -->
<div id="toc-button" class="floating-toc-button">
  Table of Contents
</div>

<!-- Expandable TOC Panel -->
<div id="toc-panel" class="toc-panel">
  <div id="toc-panel-content">
      <h4>Table of Contents</h4>
      <ol id="dynamic-toc"></ol>
  </div>
</div>



<script>
// Dynamically generate TOC from <h2> headings within <section> elements
  const tocList = document.getElementById('dynamic-toc');
const sections = document.querySelectorAll('section');
const tocButton = document.getElementById('toc-button');
const tocPanel = document.getElementById('toc-panel');

// Generate Table of Contents
sections.forEach(section => {
    const headings = section.querySelectorAll('h2');
    headings.forEach(heading => {
        const headingAnchor = heading.querySelector('a');
        if (headingAnchor && headingAnchor.getAttribute('href')) {
            const tocItem = document.createElement('li');
            const link = document.createElement('a');
            link.textContent = headingAnchor.textContent || 'Untitled Section';
            link.href = headingAnchor.getAttribute('href');
            tocItem.appendChild(link);
            tocList.appendChild(tocItem);
        }
    });
});

// Hide TOC button initially
tocButton.style.display = 'none';

// Show/hide TOC button on scroll
window.addEventListener('scroll', () => {
    // Show button after scrolling down 200 pixels
    if (window.scrollY > 200) {
        tocButton.style.display = 'block';
    } else {
        tocButton.style.display = 'none';
        tocPanel.classList.remove('expanded');
    }
});

// Toggle TOC panel
tocButton.addEventListener('click', (event) => {
    event.stopPropagation(); // Prevent immediate closure
    tocPanel.classList.toggle('expanded');
});

// Close TOC panel when clicking outside
document.addEventListener('click', (event) => {
    if (tocPanel.classList.contains('expanded') && 
        !tocPanel.contains(event.target) && 
        event.target !== tocButton) {
        tocPanel.classList.remove('expanded');
    }
});


</script>

</body>
</html>
 
